×
CLOSE
Home
About
Corporate Overview
Management
Partners
Pipeline
Pepinemab
Neurology
Pepinemab
Immuno-Oncology
Research & Development Programs
Clinical Trials
Neurology
Oncology
ActivMAb
®
Antigen Virus
In Vivo Discovery
In Vitro Discovery
Protein Optimization
Antigen Discovery
ActivMAb
®
Contact
News & Publications
News
Publications
Investors
Investor Overview
News Releases
Events
Presentations
Stock Information
Corporate Governance
Financial Information
Investor Services
Events
Presentations
Careers
Contact Us
Science in the service of medicine
About
Corporate Overview
Management
Partners
Pipeline
Pepinemab Neurology
Pepinemab Immuno-Oncology
Research & Development Programs
Clinical Trials
Neurology
Oncology
ActivMAb
®
ActivMAb
®
Antigen Virus
In Vivo Discovery
In Vitro Discovery
Protein Optimization
Antigen Discovery
Contact Us
News & Publications
News
Publications
Investors
Investor Overview
News Releases
Events
Presentations
Stock Information
Corporate Governance
Financial Information
Investor Services
Events
Presentations
Careers
Contact Us
ActivMab
®
In Vitro Discovery
Proprietary synthetic, naïve and immunized libraries
Antigen virions can be directly coated onto ELISA plates, or coupled to magnetic or polystyrene beads.
ActivMab
®
antigen virions enable antibody discovery on complex antigens using purified protein methodology.
ActivMAb
®
in Action:
Antibody Discovery for SEMA4D
Learn More
Read our 2023 paper in MAbs
Contact us for a quote or to learn more about ActivMab
®
Discovery Services
You can now easily find, order, and purchase Vaccinex’s catalog and custom services on
Science Exchange
If you are interested in learning more about ActivMab®, please email us at
activmab@vaccinex.com
.
Learn more by viewing our On-demand Webinar:
Antibody Discovery for Challenging Targets Powered by ActivMab
®
Technology
Register Now
Learn more about ActivMab
®
Technology
Antigen Virus
In Vivo Discovery
In Vitro Discovery
Protein Optimization
